The Board of Directors of Clinomics Inc. has authorized a buyback plan on August 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,436 KRW | +5.51% | -14.06% | -44.02% |
1st Jan change | Capi. | |
---|---|---|
-44.02% | 3.45Cr | |
+26.25% | 4.92TCr | |
+1.18% | 4.21TCr | |
+50.41% | 4.04TCr | |
-5.26% | 2.89TCr | |
+13.30% | 2.61TCr | |
-21.98% | 1.87TCr | |
+8.10% | 1.33TCr | |
+32.02% | 1.23TCr | |
+0.27% | 1.2TCr |
- Stock Market
- Equities
- A352770 Stock
- News Clinomics Inc.
- Clinomics Inc. authorizes a Buyback Plan.